Google Inc vs Liquidia Corporation Common Stock — how do they compare? Google Inc trades at $340.22 (market cap $4.23T), while Liquidia Corporation Common Stock trades at $33.47 (market cap $3.04B). The key difference: Google Inc is far larger — about 1391.4× Liquidia Corporation Common Stock's market cap, and Google Inc pays a 0.26% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Google Inc for 138 Days and Liquidia Corporation Common Stock for 0 Days on average.
| GOOG | LQDA | |
|---|---|---|
Market Cap | $4.23T | $3.04B |
Volume | 20,028,772 | 21,111,778 |
Sector | Media | Health |
52-Week High | $399.06 | $91.03 |
52-Week Low | $251.34 | $22.02 |
Typical Hold Time | 138 Days | 0 Days |
Enterprise Value | $4.12T | $2.94B |
Dividend Yield | 0.26% | — |
Signals from Pluang's Aura AI — not financial advice
Alphabet (GOOG) trades at $349.52, up 0.16% with strong bullish technical signals and consistent earnings beats. The company demonstrates robust fundamentals with 2025 revenue of $402.84B and net income margin of 32.8%, supported by 87% analyst buy ratings and a $435.29 consensus price target. Recent news highlights AI infrastructure investments and legal challenges, while cash flow trends show significant operational strength despite rising capital expenditures.
Outlook remains positive with AI-driven growth potential, though risks include regulatory scrutiny and capital expenditure pressures. The stock offers attractive valuation with P/E of 17.24 and strong profitability metrics, positioning it well for long-term investors despite near-term legal headwinds and competitive dynamics in the AI space.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →